Artal Group S.A. Ideaya Biosciences, Inc. Transaction History
Artal Group S.A.
- $129 Million
- Q2 2025
Shares
3 transactions
Others Institutions Holding IDYA
# of Institutions
219Shares Held
83.4MCall Options Held
28.7KPut Options Held
132K-
Black Rock Inc. New York, NY6.81MShares$188 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.55MShares$181 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X06.21MShares$172 Million0.07% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.03MShares$139 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.94MShares$137 Million0.0% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.33B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...